Search results
View Jorge A. Quiroz’s profile on LinkedIn, a professional community of 1 billion members. Biotech and pharmaceutical executive with strong experience in drug development, business…
- 500+
- NMD Pharma A/S
- 3.6K
- Cambridge, Massachusetts, United States
May 10, 2022 · Dr. Quiroz is a medical doctor and MBA with 20 years of drug development experience in academia and industry. He will lead the clinical development of NMD Pharma's pipeline of ClC-1 inhibitors for neuromuscular disorders.
May 10, 2022 · PRESS RELEASE NMD Pharma appoints Dr. Jorge A. Quiroz as EVP, Chief Medical Officer Dr. Quiroz brings extensive US and European clinical and regulatory expertiseRole will be based in Boston ...
Aug 26, 2020 · Apic Bio Announces Appointment of Jorge A. Quiroz, MD, MBA, as Executive Vice President and Chief Medical Officer. August 26, 2020 09:00 AM Eastern Daylight Time.
BioLeader Interview – Jorge Quiroz, Executive Vice President, Chief Medical Officer, NMD Pharma, Boston USA (September 2022) Dr. Quiroz brings twenty years of drug development experience in academic, pharmaceutical and biotechnology industries. He has been responsible for the scientific, clinical, and regulatory strategies across all phases ...
Mar 5, 2024 · During the meeting, NeurologyLive ® caught up with Jorge Quiroz, MD, MBA, chief medical officer of NMD Pharma, to discuss the mechanism of action of NMD670, and what it can provide for patients with SMA. He spoke on the differences of this therapy compared with previously approved products, and whether there is potential to produce synergistic ...
May 24, 2024 · Jorge Quiroz, MD, MBA March 22nd 2024 The chief medical officer of NMD Pharma provided perspective on a newly launched phase 2 study assessing NMD670, a first-in-class neuromuscular transmission enhancer, in patients with spinal muscular atrophy type 3.
